These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5860379)

  • 21. [A case of severe hypersensitivity to antitubercular drugs with multiple organ damage].
    Dukalski K; Stański K
    Gruzlica; 1969 Jul; 37(7):681-2. PubMed ID: 5350930
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of methoclopramide on the digestive tolerance of antibacillary drugs].
    Cottin S; Pinel J; de Lajartre
    Poumon Coeur; 1966; 22(6):687-91. PubMed ID: 5916006
    [No Abstract]   [Full Text] [Related]  

  • 23. [Infectiology of the urogenital tract. 7: Therapy of urogenital tuberculosis--side-effects--drugs--interactions--dose adjustment in decreased kidney function].
    Brühl P
    Fortschr Med; 1997 Jun; 115(18):44-6. PubMed ID: 9324487
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of systemic lupus erythematosus by antitubercular drugs.
    Agarwal MB; Anjaria PD; Mehta BC
    J Postgrad Med; 1980 Oct; 26(4):263-6. PubMed ID: 7230065
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypersensitive reactions to antitubercular drugs at the Tuberculosis Department of the Academy of Medicine in Szczecin, 1960-1965].
    Dobrzyński W; Fafrowicz B; Szmygin J
    Gruzlica; 1966 Jan; 34(1):47-51. PubMed ID: 5910743
    [No Abstract]   [Full Text] [Related]  

  • 26. [Side effects in pulmonary tuberculosis patients in different chemotherapy methods].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1981 Oct; (10):37-40. PubMed ID: 7312849
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vitamin A and carotene in patients with pulmonary tuberculosis with side effects of antibacterial therapy].
    Ignatova AV; Prokop'ev DI
    Probl Tuberk; 1966; 44(9):36-41. PubMed ID: 5994511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adverse effects in children receiving short-term chemotherapy for intrathoracic tuberculosis].
    Iukhimenko NV
    Probl Tuberk; 2002; (2):24-7. PubMed ID: 11899799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].
    Aouam K; Chaabane A; Loussaïef C; Ben Romdhane F; Boughattas NA; Chakroun M
    Med Mal Infect; 2007 May; 37(5):253-61. PubMed ID: 17336011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
    Dosumu EA
    Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preclinical diagnosis of the adverse effects of antibacterial drugs used in the treatment of pulmonary tuberculosis].
    Kibrik BS; Khaiutina ES
    Probl Tuberk; 1980 Jul; (7):33-7. PubMed ID: 7413632
    [No Abstract]   [Full Text] [Related]  

  • 32. [The incidence of adverse effects of drugs in a pulmonary disease clinic].
    Lorenz C; Tendler H
    Z Gesamte Inn Med; 1981 Apr; 36(8):265-9. PubMed ID: 7281833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arteritis due to allergy drugs].
    Navarro Gutiérrez R; Ayerbe Vallés SA; Vázquez Díaz J; Gimeno De La Peña L; Romero Roldán JM; Fernández Vázquez A
    Rev Esp Cardiol; 1967 Apr; 20(2):216-20. PubMed ID: 5605308
    [No Abstract]   [Full Text] [Related]  

  • 34. [Principles of drug therapy in urogenital tuberculosis].
    Jungbluth H
    Urologe A; 1984 Jul; 23(4):189-93. PubMed ID: 6540914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)].
    Eule H; Iwainsky H
    Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical studies on d-2,2'-(ethylenediimino) di-a-butanol (ethambutol or ebutol). 2. Studies on the side effects].
    Baba H; Azuma Y; Tajima Y; Futamura H; Miyata Y
    Kekkaku; 1967 Jan; 42(1):1-7. PubMed ID: 6036568
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative pharmacologic characteristics of antitubercular agents].
    Veĭs RA; Bykova MA
    Probl Tuberk; 1965; 43(9):67-71. PubMed ID: 5870633
    [No Abstract]   [Full Text] [Related]  

  • 38. [Opportunities for the evaluation of the secondary reaction of antituberculosis drugs by several indicators, determined in the blood of patients with tuberculosis of the lungs].
    Khomenko AG; Vysochina IV; Kolosovskaia VP; Efimova LN; Kuz'mina NV
    Vopr Med Khim; 1983; 29(3):83-8. PubMed ID: 6880125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antituberculous drugs and hepatotoxicity.
    Nishioka Sde A
    Am J Gastroenterol; 1996 Jul; 91(7):1471-2. PubMed ID: 8678028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lactate dehydrogenase isoenzymes in pulmonary tuberculosis patients with manifestations of the adverse effects of antitubercular preparations].
    Kotenko AP
    Probl Tuberk; 1983 Jul; (7):27-30. PubMed ID: 6634674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.